NGS Informatics Market Size, Share & Trends Report

2025

2030

Global NGS Informatics Market – Analysis and Forecast (2025-2030)

Industry Insight by Product (Data Analysis & Management Tools, Primary and Secondary Data Analysis Tools, and NGS Informatics Services), by Application (Drug Discovery, Genetic Screening, Biomarker Discovery, Diagnostics, Agriculture and Animal Research, and Precision Medicine), by End User (Pharmaceutical Companies, Academic and Research Centers, Hospitals and Clinics, and Others), and Geography (U.S., Canada, Germany, U.K., France, China, Japan, India, and Rest of the World)

Ask for Customization

Request for Sample

Industry Overview

The Global NGS (Next-Generation Sequencing) Informatics Market size is anticipated to grow from USD 1.5 billion in 2023 to USD 4.75 billion by 2030. During the forecast period, it will grow at a CAGR of 15.7%. Next-generation DNA sequencing (NGS) technology has reduced the cost of genome and RNA sequencing thereby can be used in a diverse range of research applications. Metagenomics, gene expression, epigenetics, whole-genome and transcriptome sequencing, and other applications are used in NGS informatics. Next-generation sequencing informatics makes DNA sequencing easier for researchers and organizations by utilizing bioinformatics methods. Certain benefits provided by NGS, such as cost-effectiveness, rapid and accurate sample analysis, and technological innovations, are expected to drive NGS technology during the forecast period. Furthermore, the development of genomics programs in a number of countries is expected to benefit the market for next-generation sequencing. The introduction of next-generation sequencing-based diagnosis, as well as proactive government support, are also key market growth factors.

NGS Informatics Market

Next Generation Sequencing (NGS) is regarded as a valuable tool in the characterization and identification of the SARS-CoV2 virus, as NDS technologies play an important role in studying viral genome mutations and their impact on human health.

NGS (Next-Generation Sequencing) Informatics Market Segmentation

Insight by Product

Based on Product, the Global NGS Informatics Market is segmented into Data Analysis & Management Tools, Primary and Secondary Data Analysis Tools, and NGS Informatics Services. The Data Analysis and Management Tools are further divided into Data Interpretation and Reporting Tools and Laboratory Information and Management Systems (LIMS). The data analysis and management tools contribute the largest share in the market due to increased market demand and technological development in NGS informatics tools.

Insight by Application

Based on Application, the Global NGS Informatics Market is segregated into Drug Discovery, Genetic Screening, Biomarker Discovery, Diagnostics, Agriculture and Animal Research, and Precision Medicine. The biomarker discovery is expected to witness the largest share in the market owing to the increased prominence of cancer. These biomarkers will aid in enhancing the quality of cancer treatment, thereby offering technological development in NGS informatics.

Insight by End User

Based on End-User, the Global NGS Informatics Market is divided into Pharmaceutical Companies, Academic and Research Centers, Hospitals and Clinics, and Others. The Academic and Research Centers contribute the largest share owing to the upsurge in the application-based deployment in these institutes and the mounting development of oncology research.

Global NGS Informatics Market Report Coverage

Report Metric	Details
Historical Period	2018 - 2023
Base Year Considered	2024
Forecast Period	2025 - 2030
Market Size in 2023	U.S.D. 1.5 Billion
Revenue Forecast in 2030	U.S.D. 4.75 Billion
Growth Rate	15.7%
Segments Covered in the Report	By Product, By Application and By End User
Report Scope	Market Trends, Drivers, and Restraints; Revenue Estimation and Forecast; Segmentation Analysis; Impact of COVID-19; Companies’ Strategic Developments; Market Share Analysis of Key Players; Company Profiling
Regions Covered in the Report	North America, Europe, Asia-Pacific, Middle East, and Rest of the World

Industry Dynamics

NGS (Next-Generation Sequencing) Informatics Market Growth Drivers

NGS Informatics’ main objective is to conduct genomic mapping of microorganisms to better understand the biochemistry and response of the ocean to environmental pollution, nutrient stress, and climate change. Also, the increased speed and agility provided by NGS software, an increase in investments by key players, and lower sequencing costs when using NGS informatics will all help to drive the NGS informatics industry's market development.

Also, increased clinical applications of next-generation sequencing (NGS) owing to rapid result time, flexibility, and faster processing will provide a favorable environment for the market expansion of the NGS informatics industry. The burgeoning clinical applications of NGS in oncology for the clinical management of cancer patients, as well as mutation profiling to identify subsequent treatment options, are driving up demand for NGS. Furthermore, advances in big data technology will allow for better storage and management of NGS data, resulting in increased demand for NGS and greater adoption of NGS software.

NGS (Next-Generation Sequencing) Informatics Market Challenges

Market growth will be hampered by a lack of accuracy, precision, and standardization of technology. In addition, there is a dearth of skilled labor and technicians in the market for NGS informatics services, which is impeding the market growth. Ethical and legal constraints, like access to medical records and their distribution, are also having a negative impact on the market.

NGS (Next-Generation Sequencing) Informatics Market Opportunities

Increased integration of NGS technology into other research programs, increased prominence of personalized medicines, rising cancer incidences, and untapped market opportunities in developing markets are expected to provide lucrative market opportunities in the NGS informatics industry.

NGS (Next-Generation Sequencing) Informatics Market Geographic Overview

North America
Europe
Asia Pacific (APAC)
Rest of the World (RoW)

North America is expected to contribute the largest share in the NGS Informatics market owing to the presence of high per capita healthcare expenditure, the presence of several clinical laboratories that deploy NGS to provide genetic testing services, increased awareness among patients, and the mounting prevalence of target diseases. Additionally, a number of governmental organizations, like the National Human Genome Research Institute (NHGRI) in the United States, have been sponsoring studies on the sequencing of the human genome as well as studies on the structure, functionality, and importance of the genome in health and disease. Furthermore, these organizations fund research into the ethical, legal, and social implications (ELSI) of genome research.

NGS (Next-Generation Sequencing) Informatics Market Competitive Insight

The market for next-generation sequencing informatics is consolidated, with only a few key players. Few key players presently dominate the industry in terms of market share. Few other smaller players are expected to enter the market, owing to rising patient awareness levels and the increasing incidence of chronic diseases. To stay competitive, the major players in the NGS Informatics sector are focusing on mergers and acquisitions (M&A), collaborations, partnerships, increased R&D activities, and new product launches.

In the fields of genomics and transcriptomics, Lasergene Genomics stands out. The software, which is powered by SeqMan NGen, DNASTAR's revolutionary and user-friendly assembler, allows one to set up complex genomic sequencing projects in minutes and automates tasks that would normally require extensive manual intervention in other software packages. Intuitive project setup and analysis, combined with patented assembly algorithms, enable unrivaled ease and speed in assembling and aligning NGS data, allowing you to focus on the results. There will be no need to switch between software tools to assemble sequences, identify important variants, and identify differentially expressed genes.

GENEWIZ is a leading global genomics service provider and trusted provider of Sanger sequencing, NGS, gene synthesis, molecular biology, bioinformatics, and GLP regulatory services. GENEWIZ is a recognized partner at top academic, pharmaceutical, biotechnology, agricultural, governmental, and clinical institutes and is easily accessible throughout the world. NGS Services include RNA-Seq, Single-Cell Sequencing, Sequencing Only, Whole Genome Sequencing, Exome Sequencing, Targeted Sequencing, Amplicon Sequencing, CRISPR Validation, Digital Spatial Profiling, AAV Genome Sequencing, Metagenomics Solutions, Immunogenomics, and Epigenomics.

Recent Development by Key Players

MOMA Therapeutics and Roche recently partnered for discovering drug targets for cancer. Under this collaboration, Roche will obtain access to MOMA’s KnowledgeBase platform to identify and prosecute new drug targets that are involved in the growth and survival of cancer cells.

QIAGEN Digital Insights (QDI), a QIAGEN's bioinformatics business, stated their augmented QIAGEN CLC Genomics Workbench Premium in January 2023, which removes the data-analysis bottleneck of next-generation sequencing (NGS) by adding game-changing analysis speed to analyse and interpret whole genome sequencing (WGS), whole exome sequencing (WES), and large panel sequencing data. The QIAGEN CLC Genomics Workbench Premium update includes LightSpeed technology, a software accelerator that converts raw sequencing data in FASTQ files from any paired-end short read sequencing platform into interpretable lists of genetic variants in the VCF format at an unprecedented rate. It can analyse an entire human genome at 34x coverage on a standard computer in 25 minutes and a whole exome at 50x coverage in 90 seconds in standard cloud environments. Using cloud infrastructure and QIAGEN CLC LightSpeed technology, labs can run WGS analyses for about $1 per genome and WES for a few cents per exome. Alternatively, labs can run the QIAGEN CLC LightSpeed technology on existing local hardware with comparable results.

Illumina, Inc., one of the prominent leaders in DNA sequencing and array-based technologies, announced the release of the NovaSeqTM X Series (NovaSeq X and NovaSeq X Plus), two new production-scale sequencers that will push the boundaries of genomic medicine by enabling faster, more powerful, and more sustainable sequencing.

Key Players Covered in the Report

Some of the major players operating in the NGS Informatics Market include Illumina, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, QIAGEN, Dassault Systèmes, DNASTAR, GENEWIZ, Eagle Genomics, Abbott, and Agilent Technologies, Inc.

The NGS Informatics Market report offers a comprehensive market segmentation analysis along with an estimation for the forecast period 2025–2030.

Segments Covered in the Report

By Product
- Data Analysis & Management Tools
  - Data Interpretation and Reporting Tools
  - Laboratory Information and Management Systems (LIMS)
- Primary and Secondary Data Analysis Tools
- NGS Informatics Services
By Application
- Drug Discovery
- Genetic Screening
- Biomarker Discovery
- Diagnostics
- Agriculture and Animal Research
- Precision Medicine
By End User
- Pharmaceutical Companies
- Academic and Research Centers
- Hospitals and Clinics
- Others

Region Covered in the Report

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia-Pacific (APAC)
- China
- Japan
- India
- South Korea
- Rest of Asia-Pacific
Rest of the World (RoW)
- Brazil
- Saudi Arabia
- South Africa
- U.A.E.
- Other Countries

Primary Research Interviews Breakdown

NGS Informatics Market Size

1. Research Overview

       1.1.   The Report Offers
       1.2.   Market Coverage
               1.2.1.   By Product
               1.2.2.   By Application
               1.2.3.   By End User
               1.2.4. By Region
       1.3.   Research Phases
       1.4.   Limitations
       1.5.   Market Methodology
               1.5.1.   Data Sources
                       1.5.1.1. Primary Research
                       1.5.1.2. Secondary Research
               1.5.2.   Methodology
                       1.5.2.1. Data Exploration
                       1.5.2.2. Forecast Parameters
                       1.5.2.3. Data Validation
                       1.5.2.4. Assumptions
               1.5.3.   Study Period & Data Reporting Unit

2. Executive Summary

3. Industry Overview

       3.1.   Industry Dynamics
               3.1.1.   Market Growth Drivers
               3.1.2.   Market Restraints
               3.1.3.   Key Market Trends
               3.1.4.   Major Opportunities
       3.2.   Industry Ecosystem
               3.2.1.   Porter’s Five Forces Analysis
               3.2.2.   Recent Development Analysis
               3.2.3.   Value Chain Analysis
       3.3.   Competitive Insight
               3.3.1.   Competitive Position of Industry Players
               3.3.2.   Market Attractive Analysis
               3.3.3.   Market Share Analysis

4. Global Market Estimate and Forecast

4.1. Global Market Overview
4.2. Global Market Estimate and Forecast to 2030

5. Market Segmentation Estimate and Forecast

       5.1.   By Product
               5.1.1.   Data Analysis & Management Tools
                       5.1.1.1. Market Definition
                       5.1.1.2. Market Estimation and Forecast to 2030
               5.1.2.   Primary and Secondary Data Analysis Tools
                       5.1.2.1. Market Definition
                       5.1.2.2. Market Estimation and Forecast to 2030
               5.1.3.   NGS Informatics Services
                       5.1.3.1. Market Definition
                       5.1.3.2. Market Estimation and Forecast to 2030
       5.2.   By Application
               5.2.1.   Drug Discovery
                       5.2.1.1. Market Definition
                       5.2.1.2. Market Estimation and Forecast to 2030
               5.2.2.   Genetic Screening
                       5.2.2.1. Market Definition
                       5.2.2.2. Market Estimation and Forecast to 2030
               5.2.3.   Biomarker Discovery
                       5.2.3.1. Market Definition
                       5.2.3.2. Market Estimation and Forecast to 2030
               5.2.4.   Diagnostics
                       5.2.4.1. Market Definition
                       5.2.4.2. Market Estimation and Forecast to 2030
               5.2.5.   Agriculture and Animal Research
                       5.2.5.1. Market Definition
                       5.2.5.2. Market Estimation and Forecast to 2030
               5.2.6.   Precision Medicine
                       5.2.6.1. Market Definition
                       5.2.6.2. Market Estimation and Forecast to 2030

       5.3.   By End User
               5.3.1.   Pharmaceutical Companies
                       5.3.1.1. Market Definition
                       5.3.1.2. Market Estimation and Forecast to 2030
               5.3.2.   Academic and Research Centers
                       5.3.2.1. Market Definition
                       5.3.2.2. Market Estimation and Forecast to 2030
               5.3.3.   Hospitals and Clinics
                       5.3.3.1. Market Definition
                       5.3.3.2. Market Estimation and Forecast to 2030
               5.3.4.   Others
                       5.3.4.1. Market Definition
                       5.3.5.2. Market Estimation and Forecast to 2030

6.   North America Market Estimate and Forecast

       6.1.   By Product
       6.2.   By Application
       6.3.   By End User
       6.4.   By Country
               6.4.1.   U.S. Market Estimate and Forecast
               6.4.2.   Canada Market Estimate and Forecast
               6.4.3.   Mexico Market Estimate and Forecast

7. Europe Market Estimate and Forecast

       7.1.   By Product
       7.2.   By Application
       7.3.   By End User
       7.4.   By Country
               7.4.1.   Germany Market Estimate and Forecast
               7.4.2.   France Market Estimate and Forecast
               7.4.3.   U.K. Market Estimate and Forecast
               7.4.4.   Italy Market Estimate and Forecast
               7.4.5.   Spain Market Estimate and Forecast
               7.4.6.   Rest of Europe Market Estimate and Forecast

8. Asia-Pacific Market Estimate and Forecast

       8.1.   By Product
       8.2.   By Application
       8.3.   By End User
       8.4.   By Country
               8.4.1.   China Market Estimate and Forecast
               8.4.2.   Japan Market Estimate and Forecast
               8.4.3.   India Market Estimate and Forecast
               8.4.4.   South Korea Market Estimate and Forecast
               8.4.5.   Singapore Market Estimate and Forecast
               8.4.6.   Rest of Asia-Pacific Market Estimate and Forecast

9. Rest of the World (RoW) Market Estimate and Forecast

       9.1.   By Product
       9.2.   By Application
       9.3.   By End User
       9.4. By Country
               9.4.1.   Brazil Market Estimate and Forecast
               9.4.2.   Saudi Arabia Market Estimate and Forecast
               9.4.3.   South Africa Market Estimate and Forecast
               9.4.4.   Other Countries Market Estimate and Forecast

10. Company Profiles

       10.1.   Illumina, Inc.
               10.1.1.   Snapshot
               10.1.2.   Overview
               10.1.3.   Offerings
               10.1.4.   Financial Insight
               10.1.5.   Recent Developments
       10.2.   Thermo Fisher Scientific Inc.
               10.2.1.   Snapshot
               10.2.2.   Overview
               10.2.3.   Offerings
               10.2.4.   Financial Insight
               10.2.5.   Recent Developments
       10.3. F. Hoffmann-La Roche Ltd
               10.3.1.   Snapshot
               10.3.2.   Overview
               10.3.3.   Offerings
               10.3.4.   Financial Insight
               10.3.5.   Recent Developments
       10.4.   QIAGEN
               10.4.1.   Snapshot
               10.4.2.   Overview
               10.4.3.   Offerings
               10.4.4.   Financial Insight
               10.4.5.   Recent Developments
       10.5. Dassault Systèmes
               10.5.1.   Snapshot
               10.5.2.   Overview
               10.5.3.   Offerings
               10.5.4.   Financial Insight
               10.5.5.   Recent Developments
       10.6. DNASTAR
               10.6.1.   Snapshot
               10.6.2.   Overview
               10.6.3.   Offerings
               10.6.4.   Financial Insight
               10.6.5.   Recent Developments
       10.7.   GENEWIZ
               10.7.1.   Snapshot
               10.7.2.   Overview
               10.7.3.   Offerings
               10.7.4.   Financial Insight
               10.7.5.   Recent Developments
       10.8.   Eagle Genomics
               10.8.1.   Snapshot
               10.8.2.   Overview
               10.8.3.   Offerings
               10.8.4.   Financial Insight
               10.8.5.   Recent Developments
       10.9.   Abbott
               10.9.1.   Snapshot
               10.9.2.   Overview
               10.9.3.   Offerings
               10.9.4.   Financial Insight
               10.9.5.   Recent Developments
       10.10. Agilent Technologies, Inc.
               10.10.1. Snapshot
               10.10.2. Overview
               10.10.3. Offerings
               10.10.4. Financial Insight
               10.10.5. Recent Developments

11. Appendix

11.1. Exchange Rates
11.2. Abbreviations

Note: Financial insight and recent developments of different companies are subject to availability of information in secondary domain.

List of Tables

Table 1 Sources
Table 2 Study Periods
Table 3 Data Reporting Unit
Table 4 Global NGS Informatics Market Size, By Product, 2018-2023 (USD Billion)
Table 5 Global NGS Informatics Market Size, By Product, 2025-2030 (USD Billion)
Table 6 Global NGS Informatics Market Size, By Application, 2018-2023 (USD Billion)
Table 7 Global NGS Informatics Market Size, By Application, 2025-2030 (USD Billion)
Table 8 Global NGS Informatics Market Size, By End User, 2018-2023 (USD Billion)
Table 9 Global NGS Informatics Market Size, By End User, 2025-2030 (USD Billion)
Table 10 Global NGS Informatics Market Size, by Region, 2018-2023 (USD Billion)
Table 11 Global NGS Informatics Market Size, by Region, 2025-2030 (USD Billion)
Table 12 North America NGS Informatics Market Size, By Product, 2018-2023 (USD Billion)
Table 13 North America NGS Informatics Market Size, By Product, 2025-2030 (USD Billion)
Table 14 North America NGS Informatics Market Size, By Application, 2018-2023 (USD Billion)
Table 15 North America NGS Informatics Market Size, By Application, 2025-2030 (USD Billion)
Table 16 North America NGS Informatics Market Size, By End User, 2018-2023 (USD Billion)
Table 17 North America NGS Informatics Market Size, By End User, 2025-2030 (USD Billion)
Table 18 North America NGS Informatics Market Size, by Region, 2018-2023 (USD Billion)
Table 19 North America NGS Informatics Market Size, by Region, 2025-2030 (USD Billion)
Table 20 Europe NGS Informatics Market Size, By Product, 2018-2023 (USD Billion)
Table 21 Europe NGS Informatics Market Size, By Product, 2025-2030 (USD Billion)
Table 22 Europe NGS Informatics Market Size, By Application, 2018-2023 (USD Billion)
Table 23 Europe NGS Informatics Market Size, By Application, 2025-2030 (USD Billion)
Table 24 Europe NGS Informatics Market Size, By End User, 2018-2023 (USD Billion)
Table 25 Europe NGS Informatics Market Size, By End User, 2025-2030 (USD Billion)
Table 26 Europe NGS Informatics Market Size, by Region, 2018-2023 (USD Billion)
Table 27 Europe NGS Informatics Market Size, by Region, 2025-2030 (USD Billion)
Table 28 Asia-Pacific NGS Informatics Market Size, By Product, 2018-2023 (USD Billion)
Table 29 Asia-Pacific NGS Informatics Market Size, By Product, 2025-2030 (USD Billion)
Table 30 Asia-Pacific NGS Informatics Market Size, By Application, 2018-2023 (USD Billion)
Table 31 Asia-Pacific NGS Informatics Market Size, By Application, 2025-2030 (USD Billion)
Table 32 Asia-Pacific NGS Informatics Market Size, By End User, 2018-2023 (USD Billion)
Table 33 Asia-Pacific NGS Informatics Market Size, By End User, 2025-2030 (USD Billion)
Table 34 Asia-Pacific NGS Informatics Market Size, by Region, 2018-2023 (USD Billion)
Table 35 Asia-Pacific NGS Informatics Market Size, by Region, 2025-2030 (USD Billion)
Table 36 RoW NGS Informatics Market Size, By Product, 2018-2023 (USD Billion)
Table 37 RoW NGS Informatics Market Size, By Product, 2025-2030 (USD Billion)
Table 38 RoW NGS Informatics Market Size, By Application, 2018-2023 (USD Billion)
Table 39 RoW NGS Informatics Market Size, By Application, 2025-2030 (USD Billion)
Table 40 RoW NGS Informatics Market Size, By End User, 2018-2023 (USD Billion)
Table 41 RoW NGS Informatics Market Size, By End User, 2025-2030 (USD Billion)
Table 42 RoW NGS Informatics Market Size, by Region, 2018-2023 (USD Billion)
Table 43 RoW NGS Informatics Market Size, by Region, 2025-2030 (USD Billion)
Table 44 Snapshot – Illumina, Inc.
Table 45 Snapshot – Thermo Fisher Scientific Inc.
Table 46 Snapshot – F. Hoffmann-La Roche Ltd
Table 47 Snapshot – QIAGEN
Table 48 Snapshot – Dassault Systèmes
Table 49 Snapshot – DNASTAR
Table 50 Snapshot – GENEWIZ
Table 51 Snapshot – Eagle Genomics
Table 52 Snapshot – Abbott
Table 53 Snapshot – Agilent Technologies, Inc.

List of Figures

Figure 1 Market Coverage
Figure 2 Research Phases
Figure 3 Secondary Sources for Different Parameters
Figure 4 Methodology
Figure 5 Data Mining & Exploration
Figure 6 Data Triangulation
Figure 7 Assumptions for Market Estimation and Forecast
Figure 8 Market Synopsis
Figure 9 Global NGS Informatics Market - Growth Drivers and Restraints
Figure 10 Competitive Benchmark
Figure 11 Global NGS Informatics Market Highlight
Figure 12 Global NGS Informatics Market Size, By Product, 2018-2021 (USD Billion)
Figure 13 Global NGS Informatics Market Size, By Application, 2018-2021 (USD Billion)
Figure 14 Global NGS Informatics Market Size, By End User, 2018-2021 (USD Billion)
Figure 15 Global NGS Informatics Market Size, by Region, 2018-2021 (USD Billion)
Figure 16 North America NGS Informatics Market Highlight
Figure 17 North America NGS Informatics Market Size, By Product, 2018 - 2030 (USD Billion)
Figure 18 North America NGS Informatics Market Size, By Application, 2018 - 2030 (USD Billion)
Figure 19 North America NGS Informatics Market Size, By End User, 2018 - 2030 (USD Billion)
Figure 20 North America NGS Informatics Market Size, by Region, 2018 - 2030 (USD Billion)
Figure 21 Europe NGS Informatics Market Highlight
Figure 22 Europe NGS Informatics Market Size, By Product, 2018 - 2030 (USD Billion)
Figure 23 Europe NGS Informatics Market Size, By Application, 2018 - 2030 (USD Billion)
Figure 24 Europe NGS Informatics Market Size, By End User, 2018 - 2030 (USD Billion)
Figure 25 Europe NGS Informatics Market Size, by Region, 2018 - 2030 (USD Billion)
Figure 26 Asia-Pacific NGS Informatics Market Highlight
Figure 27 Asia-Pacific NGS Informatics Market Size, By Product, 2018 - 2030 (USD Billion)
Figure 28 Asia-Pacific NGS Informatics Market Size, By Application, 2018 - 2030 (USD Billion)
Figure 29 Asia-Pacific NGS Informatics Market Size, By End User, 2018 - 2030 (USD Billion)
Figure 30 Asia-Pacific NGS Informatics Market Size, by Region, 2018 - 2030 (USD Billion)
Figure 31 RoW NGS Informatics Market Highlight
Figure 32 RoW NGS Informatics Market Size, By Product, 2018 - 2030 (USD Billion)
Figure 33 RoW NGS Informatics Market Size, By Application, 2018 - 2030 (USD Billion)
Figure 34 RoW NGS Informatics Market Size, By End User, 2018 - 2030 (USD Billion)
Figure 35 RoW NGS Informatics Market Size, by Region, 2018 - 2030 (USD Billion)

Frequently Asked Questions

What is the market size and market share for the NGS Informatics Market?

The Global NGS (Next-Generation Sequencing) Informatics Market size is anticipated to grow from USD 1.5 billion in 2023 to USD 4.75 billion by 2030. During the forecast period, it will grow at a CAGR of 15.7%.

What are the challenges impeding the market growth for the NGS Informatics MArket?

What are the factors attributing to the market growth for the NGS Informatics Market?

Factors attributing to the market growth for the NGS Informatics Market include cost-efficacy of genome and RNA sequencing, extensive deployment in research applications which include gene expression, epigenetics, metagenomics, etc., increased awareness and surging deployment of technology, continuous research and development activities, and technological development in NGS Informatics tools.

Which region dominates the NGS Informatics Industry?

Name some of the major players in the global NGS Informatics industry.

Some of the major players in the global NGS Informatics industry include Illumina, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, QIAGEN, Dassault Systèmes, DNASTAR, GENEWIZ, Eagle Genomics, Abbott, and Agilent Technologies, Inc.

Purchase Options

Enquire Before Buying